Prime Medicine
PRME
PRME
79 hedge funds and large institutions have $676M invested in Prime Medicine in 2023 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 36 increasing their positions, 13 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
4% more funds holding
Funds holding: 76 → 79 (+3)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
79
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$35.9M | |
| 2 | +$30.3M | |
| 3 | +$30.2M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$21M |
| 5 |
BlackRock
New York
|
+$20.1M |
Top Sellers
| 1 | -$65.6M | |
| 2 | -$20.8M | |
| 3 | -$9.79M | |
| 4 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$9.03M |
| 5 |
CC
Casdin Capital
New York
|
-$5.38M |